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Hand, Foot, and 
Mouth Disease 
Caused by Cox-
sackievirus A6, 
Japan, 2011
To the Editor: Coxsackievirus A6 
(CVA6) belongs to human enterovirus 
species A of the genus Enterovirus. 
According to a Japanese Infectious 
Agents Surveillance Report, this 
virus is one of the major causes of 
herpangina, an acute febrile disease 
characterized by vesicles, ulcers, 
and redness around the uvula, which 
occurs mainly in young children and 
infants. (1).
In June 2011, a sudden increase 
in cases of hand, foot, and mouth 
disease (HFMD) at pediatric sentinel 
sites (≈3,000 pediatric hospitals and 
clinics) was reported to the National 
Epidemiologic Surveillance of 
Infectious Diseases System in Japan. 
Compared with past numbers of cases 
over 30 years of surveillance, the 
number of cases of HFMD per sentinel 
site peaked in week 28 (July) of 2011 
(10.97 cases per sentinel), particularly 
in western Japan (2). According to the 
Infectious Agents Surveillance Report 
(as of September, 18, 2011), CVA6 
was detected in 709 HFMD cases 
and 156 herpangina cases throughout 
Japan (1).
Clinical samples (throat swab 
specimens and feces) obtained from 
sentinel sites in Shimane, Hyogo, 
Hiroshima, and Shizuoka, Japan, 
were screened for enteroviruses by 
using an enterovirus-speciﬁ  c reverse 
transcription PCR and sequence 
analysis of the partial viral protein 
(VP)4/VP2 or VP1 region (3). Among 
93 clinical samples from 108 HFMD 
case-patients, we identiﬁ  ed 74 case-
patients as CVA6 positive by sequence 
analysis.
On the basis of sequence 
analysis of the entire VP1 region 
(GenBank accession nos. AB649286–
AB649291), the consensus sequence 
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had 82.3%–82.5% nt identity (94.8%–
95.4% aa identity) with the prototype 
CVA6 Gdula strain (GenBank 
accession no. AY421764). CVA6 was 
not isolated from clinical samples 
in a cell culture system. Therefore, 
most CVA6 strains were identiﬁ  ed 
by molecular detection directly from 
clinical samples and sequence analysis. 
Some CVA6 strains were grown and 
isolated in suckling mice; these strains 
were antigenically identiﬁ  ed as CVA6 
by a neutralization test with speciﬁ  c 
antiserum against CVA6 (4).
In Japan, HFMD and herpangina 
are classiﬁ  ed as category V infectious 
diseases. On the basis of clinical 
diagnosis, suspected infections were 
reported by pediatric sentinel sites on a 
weekly basis to the Infectious Disease 
Surveillance Center of the National 
Institute of Infectious Diseases 
(Tokyo, Japan). Typical clinical signs 
and symptoms of HFMD cases caused 
by CVA6 were fever, mild vesicles 
in oral mucosa, and skin blisters on 
hands, arms, feet, legs, buttocks, and 
nail matrixes (Figure). Some patients 
with HFMD had onychomadesis 
(periodic shedding of the nails) 1–2 
months after onset of HFMD. Most 
cases of HFMD were self-limited. 
However, additional follow-up 
may be necessary for patients with 
onychomadesis who are treated at 
dermatology clinics.
As in other countries in the Asia–
Paciﬁ  c region, major causes of HFMD 
in Japan were CVA16 and enterovirus 
71. In 2010, enterovirus 71 was 
identiﬁ  ed as a major cause of HFMD 
(1). In contrast, CVA6 was consistently 
associated with herpangina, as were 
CVA2, CVA4, CVA5, and CVA10, but 
CVA6 was occasionally detected in 
HFMD case-patients. CVA6 was the 
major cause of herpangina in 2007, 
but an increase in the detection rate 
of CVA6 in HFMD case-patients was 
reported in Japan in 2009 (1).
HFMD outbreaks caused by 
CVA6 were reported in Singapore, 
Finland, and Taiwan in 2007–2009 
(5–8). Recent HFMD outbreaks in 
Finland and Spain were associated 
with cases of onychomadesis 1–2 
months after onset of HFMD (6,8,9). 
In Japan, cases of onychomadesis 
after onset of HFMD were reported 
in 2009 (10). Therefore, changes in 
clinical outcomes of CVA6-associated 
diseases should be investigated.
Although most HFMD cases 
caused by CVA6 in Japan were 
mild, CVA6 was also detected in 
other clinical samples, including 
cerebrospinal  ﬂ   uid from a patient 
with acute encephalitis in Hiroshima, 
which reafﬁ  rmed possible additional 
clinical manifestations during an 
HFMD outbreak caused by CVA6. 
Careful surveillance of disease 
and infectious agent activities 
are crucial in monitoring CVA6-
associated HFMD, onychomadesis, 
and neurologic diseases. Nucleotide 
identity between CVA6 strains in 
Finland (2008) (7) and Japan (2011) 
was ≈95% in the partial VP1 region. 
More detailed genetic, phenotypic, 
and epidemiologic analyses of CVA6 
are needed to determine the role of 
CVA6 in HFMD outbreaks with or 
without onychomadesis.
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Figure. Typical clinical manifestations of hand, foot, and mouth disease associated with 
coxsackievirus CVA6 in Shizuoka, Japan, June–July, 2011. A) Hand and arm of a 2.5-year-
old boy; B) foot and C) buttocks of a 6-year-old boy; D) nail matrix of a 20-month-old boy. A 
color version of this ﬁ  gure is available online (wwwnc.cdc.gov/EID/article/18/2/11-1147-F1.
htm).LETTERS
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Human and Porcine 
Hepatitis E Viruses, 
Southeastern 
Bolivia
To the Editor: Hepatitis E 
virus (HEV) genotypes 3 and 4 
are considered to be primarily 
zoonotic (1). However, recent data 
indicate that both genotypes can be 
transmitted among humans through 
other routes (2,3). Observations 
of genetic distinctiveness between 
swine and human HEV strains 
circulating within the same region 
argue against exclusivity of zoonotic 
transmission (4). A recent report 
presented a remarkable example of 
such distinction between genotype 
3 isolates in rural communities in 
southeastern Bolivia (5).
We examined HEV sequences 
obtained in that study to show the 
independent genetic origin of swine 
and human variants. Findings suggest 
disjunction between human and swine 
HEV strains in this epidemiologic 
setting, despite the potential for 
extensive cross-species exposure.
Using reference sequences from 
Lu et al. (6), we conducted subtype 
analysis of HEV open reading frame 
2 sequences at nucleotide positions 
826–1173 (GenBank accession no. 
AF060668) from isolates from 2 rural 
communities in southeastern Bolivia 
(5). Analysis showed that swine 
sequences belonged to subtype 3i and 
that the human sequences belonged to 
3e.
We collected all available 
GenBank genotype 3 sequences 
covering this genomic region for 
which the dates of collection were 
documented. Sequences were used to 
estimate the time from the most recent 
common ancestor (tMRCA) by using 
BEAST version 1.6.1 (7). Estimated 
tMRCA for GenBank sequences was 
longer than for sequences from Bolivia 
alone (Table) or for all genotype 3 
sequences together (Table).
To reduce the effect of close 
relatedness among human or swine 
HEV sequences from Bolivia on the 
tMRCA estimate, we used only 1 
representative sequence per species 
from each community in the ﬁ  nal 
analysis. This analysis identiﬁ  ed  an 
estimated tMRCA similar to that seen 
for GenBank sequences alone (Table, 
model F vs. model D). This estimate 
indicates that human and swine HEV 
isolates from southeastern Bolivia 
last shared a common ancestor ≈275 
years ago (Table, model F). Thus, 
swine HEV strains from both rural 
communities belonged to subtype 3i, 
and the human HEV strains identiﬁ  ed 
from the community of Bartolo, 
Bolivia, belonged to subtype 3e and 
shared an ancestor with swine strains 
almost 3 centuries ago.
This ﬁ  nding is surprising because 
the community of Bartolo has several 
potential risk factors for zoonotic 
transmission of HEV. There are ≈200 
humans and ≈70 swine in Bartolo (8). 
Residents are mainly native Quechua 
and Guarani with some of mixed 
Spanish ancestry who subsist at a 
low socioeconomic level. Their main 
livelihood activities are agriculture 
and breeding of animals. Free-
range pig farms are family owned. 
Because of its impoverished state, the 
community has no running water, and 
few houses have toilets. No facilities 
are suitable for safely slaughtering 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 2, February 2012  339